Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

Apotex Inc.,USA recall Paroxetine Hydroc

Apotex initiated recall of Paroxetine Hydrochloride tablets  in US for failed Impurities/degradation Specifications. Apotex Corp.,USA

Novartis recalls two Lots of Sandimmune

Sandimmune (cyclosporine oral solution) 100 mg/mL,packaged in 50 mL bottles, is indicated for the prophylaxis

FDA approves SpringWorks’ Ogsiveo (Nir

Desmoid tumors are non-cancerous, but locally aggressive and invasive soft-tissue tumors that can lead to

Glenmark recall Indomethacin and Naproxe

Glenmark has initiated a Class II recall of 37200 bottles of Indomethacin 25mg capsules and

FDA approves Astra Zeneca’s TRUQAP (ca

AstraZeneca’s TRUQAP (New Molecule Capivasertib) in combination with Faslodex (Fulvestrant) has been approved in the

Cipla Warning letter cites gaps in Compl

The Warning letter (dated November 17, 2023) follows the FDA inspection at Cipla’s Pithampur, Indore

Ascendis Pharma announces European appro

Danish Pharma firm Ascendis Pharma announced the European Commission approval for palopegteriparatide (Yorvipath), for treatment

Glenmark recall Esomeprazole Magnesium C

Glenmark Pharmaceuticals Inc., USA is recalling one lot of Esomeprazole Magnesium Delayed-Release Capsules. The recall

FDA Approves Evive Biotech’s Ryzneuta

FDA approves Evive Biotech’s Ryzneuta for the management of chemotherapy-induced neutropenia (incidence of infection, as

Bayer recall one lot of Vitrakvi (larotr

Bayer is recalling one lot of Vitrakvi® (larotrectinib) Oral Solution 20 mg/mL in 100mL glass